Altasciences

18 articles about Altasciences

• Alzamend Neuro Announces It Has Contracted With Altasciences to Conduct a Phase I Relative Bioavailability Study for AL001 for Dementia Related to Alzheimer’s Disease in September 2021

  8/17/2021

  Alzamend Neuro, Inc. today announced that it contracted Altasciences to conduct a six-month Phase I relative bioavailability study for AL001 for dementia related to Alzheimer’s disease in September 2021.

• Altasciences Acquires WCCT Global

  2/19/2021

  Altasciences announced that they have acquired WCCT Global, Inc., an early stage clinical research organization, or CRO, located in Southern California on the U.S.A.’s West Coast.

• Altasciences Wins Most Successful Early Phase Research (Preclinical & Phase I) at the 2019 CARE Awards

  5/8/2019

  Altasciences won in the Most Successful Early Phase Research category at the 2019 Clinical and Research Excellence Awards.

• Altasciences Announces Launch of New Brand and Website

  2/12/2019

  Altasciences’ companies, Preclinical Services in Seattle, Algorithme Pharma, Vince & Associates Clinical Research, and Algorithme Pharma USA, are now further united under the Altasciences brand.

• Altasciences Contributes to Positive Top-Line Phase 1 Results for Chronic Cough Drug Candidate

  12/12/2018

  Altasciences recently completed an important First-in-Human (FIH), Phase I, integrated adaptive clinical trial, including single and multiple ascending doses (SAD and MAD), Project Management, Bioanalysis, and Medical Writing, for sponsor Bellus Health.

• Altasciences Completes Acquisition of Preclinical Testing Business and Hires Key Staff

  10/1/2018

  This transaction will support Altasciences’ goal of being a mid-sized CRO that will provide talent and scale to support the preclinical and clinical markets while creating a new outsourcing paradigm for its clients.

• 

  Movers and Shakers for Sept. 10

  9/10/2018

  Let's take a look at who made a splash in the pharma and biotech world the past week.

• Altasciences Initiates Expansion of Bioanalytical Laboratory

  8/20/2018

  Altasciences announced today that construction work has begun on the expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical services. The additional space will include a fully-equipped, state-of-the-art lab dedicated to ligand binding and cell based assays.

• Altasciences to Acquire Preclinical Safety Testing Services

  8/15/2018

  Altasciences announced today that it has signed a definitive agreement to acquire the preclinical testing business of SNBL U.S.A.

• Altasciences’ Chris Perkin Honored as One of 100 Most Inspiring Leaders  in the Life Sciences Industry

  8/8/2018

  Altasciences is pleased to announce that, for a fourth consecutive year, CEO Chris Perkin has been honored as one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine.

• Altasciences Establishes Strategic Alliance with Altreos Research Partners

  5/23/2018

  Vince & Associates Clinical Research, an Altasciences company, announced today their strategic alliance with Altreos Research Partners.

• Vince & Associates, An Altasciences Company, To Evaluate Marijuana Compound In Clinical Trial

  10/11/2017

• Altasciences Clinical Research Offers Innovative Cannabis Research Solutions

  8/25/2017

• Audax Private Equity Announces The Acquisition Of Altasciences

  6/13/2017

• Altasciences Clinical Research Companies Recognized For Leadership

  3/15/2017

• Altasciences Clinical Research Companies Recognized For Leadership

  3/23/2016

• Two Altasciences Executives Named Pharmavoice 100 Most Inspiring People In The Life-Sciences Industry

  8/4/2015

• Altasciences And ITR Laboratories Form A Strategic Alliance

  3/5/2015